|
|
| Line 1: |
Line 1: |
| __NOTOC__
| |
| {{SI}}
| |
| {{CMG}}; {{AE}} {{AV}}
| |
|
| |
|
| ==Overview==
| |
| {{PAGENAME}} refers to a regimen consisting of [[fludarabine]] , [[amsacrine]] , and [[ara-c]] used to treat xxx.<ref name="pmid21963618">{{cite journal| author=Saure C, Schroeder T, Zohren F, Groten A, Bruns I, Czibere A et al.| title=Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen. | journal=Biol Blood Marrow Transplant | year= 2012 | volume= 18 | issue= 3 | pages= 466-72 | pmid=21963618 | doi=10.1016/j.bbmt.2011.09.006 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21963618 }} </ref>
| |
|
| |
| ==Regimen==
| |
| {{chemo|FL|Fludarabine}}
| |
|
| |
| {{chemo|AMS|Amsacrine}}
| |
|
| |
| {{chemo|A|Ara-c}}
| |
|
| |
| ==Indications==
| |
|
| |
|
| |
| ==References==
| |
| {{Reflist|2}}
| |
|
| |
| [[Category:Chemotherapy regimens]]
| |